Body mass index is associated with prognosis in Japanese elderly patients with atrial fibrillation: an observational study from the outpatient clinic

Heart and Vessels

Volumn 31, Issue 9, 2016, Pages 1553-1561

  Yanagisawa, Satoshi ^a,b   Inden, Yasuya ^a   Yoshida, Naoki ^a   Kato, Hiroyuki ^a   Miyoshi Fujii, Aya ^a   Mizutani, Yoshiaki ^a   Ito, Tadahiro ^a   Kamikubo, Yosuke ^a   Kanzaki, Yasunori ^a   Hirai, Makoto ^c   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Chunichi Hospital   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; Body mass index; Elderly; Obesity paradox; Prognosis

Indexed keywords

ACUTE CORONARY SYNDROME; AGED; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; BODY WEIGHT; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK; UNDERWEIGHT; AGE; ASIAN CONTINENTAL ANCESTRY GROUP; COMPLICATION; ELECTROCARDIOGRAPHY; ETHNOLOGY; GERIATRIC ASSESSMENT; JAPAN; KAPLAN MEIER METHOD; MORTALITY; OUTPATIENT DEPARTMENT; PROGNOSIS; UNIVERSITY HOSPITAL; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; BODY MASS INDEX; ELECTROCARDIOGRAPHY; FEMALE; GERIATRIC ASSESSMENT; HOSPITALS, UNIVERSITY; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; OBESITY; OUTPATIENT CLINICS, HOSPITAL; PROGNOSIS; RISK FACTORS; THINNESS;

EID: 84945268060     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-015-0765-y     Document Type: Article

References (34)

1. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJ, Solomon SD, Investigators CHARM (2007) Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Circulation 116:627–636
2. Shah R, Gayat E, Januzzi JL Jr, Sato N, Cohen-Solal A, diSomma S, Fairman E, Harjola VP, Ishihara S, Lassus J, Maggioni A, Metra M, Mueller C, Mueller T, Parenica J, Pascual-Figal D, Peacock WF, Spinar J, van Kimmenade R, Mebazaa A, GREAT (Global Research on Acute Conditions Team) Network (2014) Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol 63:778–785
3. Potapov EV, Loebe M, Anker S, Stein J, Bondy S, Nasseri BA, Sodian R, Hausmann H, Hetzer R (2003) Impact of body mass index on outcome in patients after coronary artery bypass grafting with and without valve surgery. Eur Heart J 24:1933–1941
4. Nikolsky E, Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Negoita M, Lansky AJ, Mehran R (2006) Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction. Am Heart J 151:168–175
5. Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, Goto D, Yokota T, Goto K, Yamada S, Yokoshiki H, Takeshita A, Tsutsui H, Investigators JCARE-CARD (2010) Body mass index is an independent predictor of long-term outcomes in patients hospitalized with heart failure in Japan. Circ J 74:2605–2611
6. Reeves BC, Ascione R, Chamberlain MH, Angelini GD (2003) Effect of body mass index on early outcomes in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol 42:668–676
7. Wang TJ, Parise H, Levy D, D’Agostino RB Sr, Wolf PA, Vasan RS, Benjamin EJ (2004) Obesity and the risk of new-onset atrial fibrillation. JAMA 292:2471–2477
8. Maeno K, Kasai T, Kasagi S, Kawana F, Ishiwata S, Ohno M, Yamaguchi T, Narui K (2013) Relationship between atrial conduction delay and obstructive sleep apnea. Heart Vessels 28:639–645
9. Badheka AO, Rathod A, Kizilbash MA, Garg N, Mohamad T, Afonso L, Jacob S (2010) Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am J Med 123:646–651
10. Ardestani A, Hoffman HJ, Cooper HA (2010) Obesity and outcomes among patients with established atrial fibrillation. Am J Cardiol 106:369–373
11. Wang J, Yang YM, Zhu J, Zhang H, Shao XH, Tian L, Huang B, Yu LT, Gao X, Wang M (2014) Overweight is associated with improved survival and outcomes in patients with atrial fibrillation. Clin Res Cardiol 103:533–542
12. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370–2375
13. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB (2003) The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 163:427–436
14. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL (1998) The effect of age on the association between body-mass index and mortality. N Engl J Med 338:1–7
15. Jensen GL (2005) Obesity and functional decline: epidemiology and geriatric consequences. Clin Geriatr Med 21:677–687
16. Matsuzawa Y, Inoue S, Ikeda Y, Sakata T, Saito Y, Sato Y, Shirai A, Ohno M, Miyazaki S, Tokunaga K, Fukagawa K, Yamanouchi K, Nakamura T (2000) Atarashii himan no hantei to himanshou no shindan kijun (New diagnostic criteria for obesity and obesity disease). J Japan Soc Study Obesity 6:18–28 [in Japanese]
17. Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P, Inoue S (2002) Criteria and classification of obesity in Japan and Asia-Oceania. Asia Pac J Clin Nutr 11:S732–S737
18. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864–2870
19. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263–272
20. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992
21. Suzuki S, Sagara K, Otsuka T, Kano H, Matsuno S, Takai H, Uejima T, Oikawa Y, Koike A, Nagashima K, Kirigaya H, Yajima J, Tanabe H, Sawada H, Aizawa T, Yamashita T (2013) Effects of smoking habit on the prevalence of atrial fibrillation in Japanese patients with special reference to sex differences. Circ J 77:2948–2953
22. Overvad TF, Rasmussen LH, Skjøth F, Overvad K, Lip GY, Larsen TB (2013) Body mass index and adverse events in patients with incident atrial fibrillation. Am J Med 126:640.e9–e17
23. Murray DR, Freeman GL (2003) Proinflammatory cytokines: predictors of a failing heart? Circulation 107:1460–1462
24. Li J, Solus J, Chen Q, Rho YH, Milne G, Stein CM, Darbar D (2010) Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm 7:438–444
25. Soeki T, Bando S, Uematsu E, Matsuura T, Niki T, Ise T, Kusunose K, Hotchi J, Ueda Y, Tomita N, Yamaguchi K, Yagi S, Fukuda D, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Sata M (2014) Pentraxin 3 is a local inflammatory marker in atrial fibrillation. Heart Vessels 29:653–658
26. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, Poole-Wilson PA, Coats AJ (1997) Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96:526–534
27. Heineke J, Auger-Messier M, Xu J, Sargent M, York A, Welle S, Molkentin JD (2010) Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation 121:419–425
28. Workman AJ (2010) Cardiac adrenergic control and atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol 381:235–249
29. Dorner TE, Rieder A (2012) Obesity paradox in elderly patients with cardiovascular diseases. Int J Cardiol 155:56–65
30. Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW (1999) Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 277:E971–E975
31. Steinberg BA, Cannon CP, Hernandez AF, Pan W, Peterson ED, Fonarow GC (2007) Medical therapies and invasive treatments for coronary artery disease by body mass: the “obesity paradox” in the Get With The Guidelines database. Am J Cardiol 100:1331–1335
32. Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P (2012) Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ 345:e4439
33. Lavie CJ, Cahalin LP, Chase P, Myers J, Bensimhon D, Peberdy MA, Ashley E, West E, Forman DE, Guazzi M, Arena R (2013) Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc 88:251–258
34. Gelber RP, Gaziano JM, Orav EJ, Manson JE, Buring JE, Kurth T (2008) Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol 52:605–615